InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: lt2211 post# 69185

Friday, 07/22/2016 8:09:20 PM

Friday, July 22, 2016 8:09:20 PM

Post# of 463610
“Past presentations haven't caused much positive comment from any respected experts on Alzheimer's disease. I expect the same with this presentation.”

The “respected experts” are all Alzheimer’s researchers — who are entrenched in the idea that Alzheimer’s disease is caused by a-beta plaques and/or tau tangles, and therefore, the only viable treatment can be some agent that removes or inhibits the deposit of these neuron wastes. Or, worse, AD simply can’t be prevented and can only be treated by acetylcholinesterase inhibitors, to provide, for a short time, slightly increased cognition.

For the experts to comment positively on Anavex’s entirely different and unique approach is to effectively admit that the research they are getting paid for is rather worthless.

Consequently, they will stay quietly in the wings, letting things play out (hoping that FDA approval of 2-73 doesn’t — as it will — completely terminate their entire research careers).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News